News Brief for AZBio MembersContinue reading
Category Archives: AZBio News
TGen scientists find likely genetic source of muscle weakness in six previously undiagnosed children
Simple genetic test by TGen reveals likely causes of disease, after other extensive testing failed; one child’s case produces discoveryContinue reading
Ducey signs legislation to allow lab testing without a doctor’s order
By: Howard Fischer, Capitol Media Services April 7, 2015 , 6:00 am (Republished with permission.)
Arizonans who want to want to run their own lab tests will soon be able to do so without first visiting a doctor.
But your insurance company won’t pick up the tab.
Hoya Group Invests in SalutarisMD Wet AMD Therapy Technology
HOYA Group has closed financing in Salutaris Medical Devices (SalutarisMD®). SalutarisMD will use the funding to further its growth strategy in developing its patented medical device designed for minimally invasive therapy of wet age-related macular degeneration (wet AMD). Wet AMD is a leading cause of vision loss and blindness that primarily affects older adults.
Flagship Biosciences reaches milestone with “fit-for-purpose” digital pathology services
Flagship Biosciences’ completes its 400th study with tissue image analysis, and fit-for-purpose IHC and ISH assay development
Continue reading
Flinn Takes To The Road with 2014 Arizona Bioscience Roadmap Report
The Flinn Foundation hosted three Bioscience Roadmap luncheons on March 31st in Phoenix, on April 1st in Tucson, and on April 2nd in Flagstaff to highlight the growth of Arizona’s bioscience sector over the past year, with a special focus on progress in bioscience entrepreneurship and economic development.Continue reading
C-Path Celebrates Its 10th Year and Current Achievements
2015 marks C-Path’s tenth year of operations. What began as a start-up organization with six people in 2005 has grown into a team of 49 committed scientists, project managers, data standards developers, database platform experts, and others leading eight consortia of over 1300 other scientists around the globe all working toward one goal: speeding the pace of medical product development.Continue reading
Zebrafish accelerate research against pancreatic cancer
Tiny transparent fish share many human characteristics; could help find compounds preventing spread of pancreatic tumors
Continue reading
World renowned surgeon joins VisionGate’s Medical Advisory Board
PHOENIX, Ariz. (April 1, 2015) – VisionGate, Inc. a company that has developed a non-invasive test for the early detection of lung cancer, LuCED®, is proud to announce that nationally renowned thoracic surgeon Dr. Harvey Pass has joined its Medical Advisory Board.Continue reading